These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3301604)

  • 1. [An evaluation of insulin requirement of diabetic patients by glucagon test].
    Kunihiro K
    Fukuoka Igaku Zasshi; 1987 Apr; 78(4):150-63. PubMed ID: 3301604
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve.
    Shima K; Tanaka R; Morishita S; Tarui S; Kumahara Y
    Diabetes; 1977 Aug; 26(8):717-25. PubMed ID: 885295
    [No Abstract]   [Full Text] [Related]  

  • 3. Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
    Dorkhan M; Tripathy D; Malm G; Asgharian H; Tuomi T; Groop L
    J Intern Med; 2008 Jul; 264(1):62-71. PubMed ID: 18298489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous insulin secretion measured by C-peptide in maturity-onset diabetes controllable by diet alone.
    Rendell M; Ross DA; Drew HM; Zarriello J
    Arch Intern Med; 1981 Nov; 141(12):1617-22. PubMed ID: 7030247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of glucose, glucagon and standard meal-induced insulin release in patients with newly onset non-insulin-dependent diabetes mellitus.
    Tai WH; Jap TS; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Nov; 42(5):353-8. PubMed ID: 3076501
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagon stimulation test for estimating endogenous insulin secretion in dogs.
    Fall T; Holm B; Karlsson A; Ahlgren KM; Kämpe O; von Euler H
    Vet Rec; 2008 Aug; 163(9):266-70. PubMed ID: 18757903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of insulin secretory capacity in diabetes mellitus.
    Horwitz DL; Rubenstein AH
    Hum Pathol; 1979 May; 10(3):257-66. PubMed ID: 381153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide response to glucagon challenge is correlated with improvement of early insulin secretion by liraglutide treatment.
    Takabe M; Matsuda T; Hirota Y; Hashimoto N; Nakamura T; Sakaguchi K; Ogawa W; Seino S
    Diabetes Res Clin Pract; 2012 Dec; 98(3):e32-5. PubMed ID: 23068961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HLA antigens, hormonal profile and insulin antibodies in insulin-dependent diabetes mellitus with retinopathy].
    Vasiukova EA; Guliaeva ES; Kantsel'son LA; Kniazev IuA; Mikhaĭlova NA
    Klin Med (Mosk); 1981 Nov; 59(11):42-6. PubMed ID: 7033655
    [No Abstract]   [Full Text] [Related]  

  • 11. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucagon-C-peptide test as a measure of insulin requirement in type 2 diabetes: evaluation of stopping insulin therapy in eleven patients.
    Viikari J; Rönnemaa T; Koskinen P
    Ann Clin Res; 1987; 19(3):178-82. PubMed ID: 3314647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin/glucagon relationship in spontaneous diabetic remission].
    Cresto JC; Sires JM; Ramos O; Abdenur JE; Basabe JC
    Medicina (B Aires); 1991; 51(3):195-203. PubMed ID: 1821901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic hormone secretion in patients with newly detected diabetes mellitus].
    Belovalova IM; Kniazeva AP; Starosel'tseva LK; Perelygina AA
    Probl Endokrinol (Mosk); 1988; 34(6):3-6. PubMed ID: 3070538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired insulin secretion in Japanese diabetic subjects with an A-to-G mutation at nucleotide 8296 of the mitochondrial DNA in tRNA(Lys).
    Kameoka K; Isotani H; Tanaka K; Kitaoka H; Ohsawa N
    Diabetes Care; 1998 Nov; 21(11):2034-5. PubMed ID: 9802769
    [No Abstract]   [Full Text] [Related]  

  • 18. [High-degree obesity--a risk factor for the development of diabetes mellitus].
    Borisova AM; Koev D; Kirilov G
    Vutr Boles; 1990; 29(3):74-8. PubMed ID: 2284804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 20. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
    Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.